Published in Proc Natl Acad Sci U S A on April 15, 1993
Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol (1996) 1.89
Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol Ther (2005) 1.61
Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector. J Virol (1995) 1.05
Characterization of promoter function and cell-type-specific expression from viral vectors in the nervous system. J Virol (2000) 1.01
Regulatable gene expression systems for gene therapy. Curr Gene Ther (2006) 0.92
Sparing of neuronal function postseizure with gene therapy. Proc Natl Acad Sci U S A (2000) 0.89
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications. Neoplasia (1999) 0.88
The potential roles of 18F-FDG-PET in management of acute stroke patients. Biomed Res Int (2013) 0.84
An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells. J Neurochem (1995) 0.84
Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss. Proc Natl Acad Sci U S A (1995) 0.83
Herpes simplex virus-based vectors. Int J Exp Pathol (2004) 0.80
Neighbor effects of neurons bearing protective transgenes. Brain Res (2010) 0.80
Neuroprotective potential of a viral vector system induced by a neurological insult. Proc Natl Acad Sci U S A (2000) 0.78
The pIC plasmid and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation. Gene (1984) 9.86
The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell (1982) 5.10
Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein. Proc Natl Acad Sci U S A (1986) 4.40
Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol (1989) 4.25
A DNA binding protein specific for an origin of replication of herpes simplex virus type 1. Proc Natl Acad Sci U S A (1986) 3.24
Temperature-sensitive mutants of herpes simplex virus type 1 defective in lysis but not in transformation. J Virol (1975) 2.92
Signals for site-specific cleavage of HSV DNA: maturation involves two separate cleavage events at sites distal to the recognition sequences. Cell (1985) 2.74
Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology (1988) 2.17
Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc Natl Acad Sci U S A (1989) 2.05
Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem (1990) 2.04
A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons. Science (1988) 2.02
Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. Virology (1988) 1.60
A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons. Neuron (1990) 1.57
Herpes simplex virus type 1 recombination: role of DNA replication and viral a sequences. J Virol (1992) 1.52
Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol (1988) 1.29
An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci U S A (1990) 1.23
Biosynthetic precursors and in vitro translation products of the glucose transporter of human hepatocarcinoma cells, human fibroblasts, and murine preadipocytes. J Biol Chem (1985) 1.22
Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci U S A (1992) 1.21
Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying alpha- and beta-regulated gene chimeras. Proc Natl Acad Sci U S A (1984) 1.19
Expression of a cellular gene cloned in herpes simplex virus: rabbit beta-globin is regulated as an early viral gene in infected fibroblasts. J Virol (1987) 1.19
Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol (1990) 1.13
Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology (1990) 1.12
In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum Gene Ther (1992) 1.11
Glucocorticoids, hippocampal damage and the glutamatergic synapse. Prog Brain Res (1990) 1.09
Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins. Virology (1992) 1.09
Glucocorticoids exacerbate hypoxic and hypoglycemic hippocampal injury in vitro: biochemical correlates and a role for astrocytes. J Neurochem (1992) 1.00
Transduction of the Chinese hamster ovary aprt gene by herpes simplex virus. J Virol (1984) 0.96
The herpes simplex virus amplicon. IV. Efficient expression of a chimeric chicken ovalbumin gene amplified within defective virus genomes. Virology (1985) 0.93
Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells. Mol Cell Biol (1988) 0.92
Introduction of a foreign gene (Escherichia coli lacZ) into rat neostriatal neurons using herpes simplex virus mutants: a light and electron microscopic study. Exp Neurol (1992) 0.91
Circadian and light-induced expression of immediate early gene mRNAs in the rat suprachiasmatic nucleus. Brain Res Mol Brain Res (1992) 0.80
Expression of human immunodeficiency virus type 1 gag gene using genetically engineered herpes simplex virus type 1 recombinants. Virus Genes (1990) 0.77
Cloning of reiterated and nonreiterated herpes simplex virus 1 sequences as BamHI fragments. Proc Natl Acad Sci U S A (1980) 6.66
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol Aging (2000) 6.47
Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst (2000) 4.50
Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell (1980) 4.47
Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts. J Virol (1985) 4.39
Structure and role of the herpes simplex virus DNA termini in inversion, circularization and generation of virion DNA. Cell (1982) 4.36
Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. J Virol (1989) 4.25
The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev (1986) 4.21
Stress and cognitive function. Curr Opin Neurobiol (1995) 4.12
NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J (1989) 3.58
Site-specific inversion sequence of the herpes simplex virus genome: domain and structural features. Proc Natl Acad Sci U S A (1981) 3.45
Herpesvirus-dependent amplification and inversion of cell-associated viral thymidine kinase gene flanked by viral a sequences and linked to an origin of viral DNA replication. Proc Natl Acad Sci U S A (1982) 3.44
Reproduction and resistance to stress: when and how. J Neuroendocrinol (2003) 3.33
A DNA binding protein specific for an origin of replication of herpes simplex virus type 1. Proc Natl Acad Sci U S A (1986) 3.24
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A (1999) 3.22
A cis-acting element within the 5' leader of a cytomegalovirus beta transcript determines kinetic class. Cell (1986) 3.20
Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A (1998) 3.12
Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc Natl Acad Sci U S A (1987) 3.04
Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A (1994) 3.03
Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J Virol (1992) 2.95
Are subordinates always stressed? A comparative analysis of rank differences in cortisol levels among primates. Horm Behav (2003) 2.90
Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A (1996) 2.87
Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol (1998) 2.86
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 2.80
Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res (1986) 2.73
Herpes simplex virus 1 helicase-primase: a complex of three herpes-encoded gene products. Proc Natl Acad Sci U S A (1989) 2.64
Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site. J Virol (1991) 2.61
Human cytomegalovirus infection inhibits G1/S transition. J Virol (1997) 2.61
Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol (1994) 2.52
Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci U S A (1999) 2.51
The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes. J Virol (1985) 2.46
Effect of neonatal handling on age-related impairments associated with the hippocampus. Science (1988) 2.41
Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J Virol (1988) 2.35
Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci (1985) 2.34
Molecular evolution of herpesviruses: genomic and protein sequence comparisons. J Virol (1994) 2.34
Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology (1988) 2.17
DNA of human cytomegalovirus: size heterogeneity and defectiveness resulting from serial undiluted passage. J Virol (1979) 2.16
Quantitative analysis of latent human cytomegalovirus. J Virol (1999) 2.11
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J Gen Virol (1995) 2.10
Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci U S A (2001) 2.10
Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region. Proc Natl Acad Sci U S A (1992) 2.09
Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci (1989) 2.07
Herpes simplex virus latent RNA (LAT) is not required for latent infection in the mouse. Proc Natl Acad Sci U S A (1989) 2.05
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette. J Virol (1994) 1.98
Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol (1998) 1.94
Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science (1985) 1.91
Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J Virol (1996) 1.90
Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci U S A (1984) 1.85
Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J Virol (1989) 1.83
Cytomegalovirus determinant of replication in salivary glands. J Virol (1992) 1.82
Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood (1992) 1.76
A method to identify distinctive charge configurations in protein sequences, with application to human herpesvirus polypeptides. J Mol Biol (1989) 1.75
Restructuring the neuronal stress response with anti-glucocorticoid gene delivery. Nat Neurosci (2004) 1.72
A DNA helicase induced by herpes simplex virus type 1. Nucleic Acids Res (1988) 1.70
Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis (1995) 1.69
Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology (1997) 1.66
Behavioral, endocrine, and immunological correlates of immigration by an aggressive male into a natural primate group. Horm Behav (1992) 1.61
Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse. Virology (1988) 1.60
A cytomegalovirus protein with properties of herpes simplex virus ICP8: partial purification of the polypeptide and map position of the gene. J Virol (1987) 1.55
Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci U S A (1999) 1.53
Herpes simplex virus type 1 recombination: role of DNA replication and viral a sequences. J Virol (1992) 1.52
Precise localization of genes on large animal virus genomes: use of lambda gt11 and monoclonal antibodies to map the gene for a cytomegalovirus protein family. Proc Natl Acad Sci U S A (1985) 1.50
The cleavage recognition signal is contained within sequences surrounding an a-a junction in herpes simplex virus DNA. Virology (1988) 1.49
Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent. Brain Res (1990) 1.46
Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology (1995) 1.44
Nucleotide sequence and structural features of a novel US-a junction present in a defective herpes simplex virus genome. J Virol (1985) 1.44
Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med (1998) 1.43
Persistence of the cytomegalovirus genome in human cells. J Virol (1979) 1.39
Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology (1984) 1.38
Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J Neurosci (1996) 1.37
Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J Infect Dis Suppl (1995) 1.37
Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol (2001) 1.37
A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus a sequence. J Virol (1989) 1.36
Glucocorticoids may enhance oxygen radical-mediated neurotoxicity. Neurotoxicology (1997) 1.36
The endocrine stress-response and social status in the wild baboon. Horm Behav (1982) 1.33
The neuroprotective potential of heat shock protein 70 (HSP70). Mol Med Today (1999) 1.33
Peripheral blood CD14(+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood (1999) 1.33
Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells. J Virol (1994) 1.32
Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication. J Virol (2001) 1.28
Memory retrieval impairment induced by hippocampal CA3 lesions is blocked by adrenocortical suppression. Nat Neurosci (2001) 1.27
Structure and variability of the a sequence in the genome of human cytomegalovirus (Towne strain). J Gen Virol (1987) 1.27
Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis. J Gen Virol (1989) 1.26
Membrane glycoproteins and antigens induced by human cytomegalovirus. J Gen Virol (1979) 1.23
Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis (1984) 1.22
Human cytomegalovirus late protein encoded by ie2: a trans-activator as well as a repressor of gene expression. J Gen Virol (1994) 1.21
Sequences within the herpesvirus-conserved pac1 and pac2 motifs are required for cleavage and packaging of the murine cytomegalovirus genome. J Virol (1998) 1.15
A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J Neurosci (1985) 1.15
Basolateral amygdala regulation of adult hippocampal neurogenesis and fear-related activation of newborn neurons. Mol Psychiatry (2011) 1.15
Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J Neurosci (1986) 1.15
The adrenocortical stress-response in the aged male rat: impairment of recovery from stress. Exp Gerontol (1983) 1.14
Stress-induced suppression of testicular function in the wild baboon: role of glucocorticoids. Endocrinology (1985) 1.14
Regulation of intracellular pH in cultured hippocampal neurons by an amiloride-insensitive Na+/H+ exchanger. J Biol Chem (1991) 1.13
Evolving concepts about the role of acidosis in ischemic neuropathology. J Neurochem (1993) 1.12
Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J Neurochem (1991) 1.12
Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology (1990) 1.12
Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia. Stroke (2001) 1.11
Overexpression of HSP72 after induction of experimental stroke protects neurons from ischemic damage. J Cereb Blood Flow Metab (2001) 1.10
Neutralizing epitopes on herpes simplex virus-1-expressed rotavirus VP7 are dependent on coexpression of other rotavirus proteins. Virology (1992) 1.09